Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 11

1.

Human halothane metabolism, lipid peroxidation, and cytochromes P(450)2A6 and P(450)3A4.

Kharasch ED, Hankins DC, Fenstamaker K, Cox K.

Eur J Clin Pharmacol. 2000 Feb-Mar;55(11-12):853-9.

PMID:
10805064
2.

Single-dose methoxsalen effects on human cytochrome P-450 2A6 activity.

Kharasch ED, Hankins DC, Taraday JK.

Drug Metab Dispos. 2000 Jan;28(1):28-33.

PMID:
10611136
3.

Lack of single-dose disulfiram effects on cytochrome P-450 2C9, 2C19, 2D6, and 3A4 activities: evidence for specificity toward P-450 2E1.

Kharasch ED, Hankins DC, Jubert C, Thummel KE, Taraday JK.

Drug Metab Dispos. 1999 Jun;27(6):717-23.

PMID:
10348802
4.

Clinical isoflurane metabolism by cytochrome P450 2E1.

Kharasch ED, Hankins DC, Cox K.

Anesthesiology. 1999 Mar;90(3):766-71.

PMID:
10078678
5.

Single-dose disulfiram does not inhibit CYP2A6 activity.

Kharasch ED, Hankins DC, Baxter PJ, Thummel KE.

Clin Pharmacol Ther. 1998 Jul;64(1):39-45.

PMID:
9695717
6.

Role of the renal cysteine conjugate beta-lyase pathway in inhaled compound A nephrotoxicity in rats.

Kharasch ED, Hoffman GM, Thorning D, Hankins DC, Kilty CG.

Anesthesiology. 1998 Jun;88(6):1624-33.

PMID:
9637657
7.

Determination of the halothane metabolites trifluoroacetic acid and bromide in plasma and urine by ion chromatography.

Hankins DC, Kharasch ED.

J Chromatogr B Biomed Sci Appl. 1997 May 9;692(2):413-8.

PMID:
9188831
8.

Cytochrome P450 2E1 is the principal catalyst of human oxidative halothane metabolism in vitro.

Spracklin DK, Hankins DC, Fisher JM, Thummel KE, Kharasch ED.

J Pharmacol Exp Ther. 1997 Apr;281(1):400-11.

PMID:
9103523
9.

Role of renal cysteine conjugate beta-lyase in the mechanism of compound A nephrotoxicity in rats.

Kharasch ED, Thorning D, Garton K, Hankins DC, Kilty CG.

Anesthesiology. 1997 Jan;86(1):160-71.

PMID:
9009951
11.

Supplemental Content

Loading ...
Support Center